Frederick Innovative Technology Center
U.S. Tax Overhaul Makes Biotech Players Hungry For Big Deals
Industry analysts are predicting that 2018 will turn out to be a banner year for merger and acquisition activity in the biotech/pharma sector, with up to $200 billion in assets changing hands.